| UniProt ID | TRI39_HUMAN | |
|---|---|---|
| UniProt AC | Q9HCM9 | |
| Protein Name | E3 ubiquitin-protein ligase TRIM39 | |
| Gene Name | TRIM39 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 518 | |
| Subcellular Localization | Cytoplasm, cytosol . Mitochondrion . Found predominantly in the cytosol. Partial shift from the cytosol to the mitochondria when colocalized with MOAP1. | |
| Protein Description | E3 ubiquitin-protein ligase. May facilitate apoptosis by inhibiting APC/C-Cdh1-mediated poly-ubiquitination and subsequent proteasome-mediated degradation of the pro-apoptotic protein MOAP1.. | |
| Protein Sequence | MAETSLLEAGASAASTAAALENLQVEASCSVCLEYLKEPVIIECGHNFCKACITRWWEDLERDFPCPVCRKTSRYRSLRPNRQLGSMVEIAKQLQAVKRKIRDESLCPQHHEALSLFCYEDQEAVCLICAISHTHRAHTVVPLDDATQEYKEKLQKCLEPLEQKLQEITRCKSSEEKKPGELKRLVESRRQQILREFEELHRRLDEEQQVLLSRLEEEEQDILQRLRENAAHLGDKRRDLAHLAAEVEGKCLQSGFEMLKDVKSTLEKNIPRKFGGSLSTICPRDHKALLGLVKEINRCEKVKTMEVTSVSIELEKNFSNFPRQYFALRKILKQLIADVTLDPETAHPNLVLSEDRKSVKFVETRLRDLPDTPRRFTFYPCVLATEGFTSGRHYWEVEVGDKTHWAVGVCRDSVSRKGELTPLPETGYWRVRLWNGDKYAATTTPFTPLHIKVKPKRVGIFLDYEAGTLSFYNVTDRSHIYTFTDTFTEKLWPLFYPGIRAGRKNAAPLTIRPPTDWE | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 92 | Ubiquitination | GSMVEIAKQLQAVKR HHHHHHHHHHHHHHH | 58.14 | 21890473 | |
| 92 (in isoform 1) | Ubiquitination | - | 58.14 | 21890473 | |
| 92 | Ubiquitination | GSMVEIAKQLQAVKR HHHHHHHHHHHHHHH | 58.14 | 21890473 | |
| 92 (in isoform 2) | Ubiquitination | - | 58.14 | 21890473 | |
| 92 | Ubiquitination | GSMVEIAKQLQAVKR HHHHHHHHHHHHHHH | 58.14 | 21890473 | |
| 98 | Acetylation | AKQLQAVKRKIRDES HHHHHHHHHHHCCCC | 51.49 | 7492131 | |
| 147 | Phosphorylation | VVPLDDATQEYKEKL EEECCHHHHHHHHHH | 29.00 | 21214269 | |
| 150 | Phosphorylation | LDDATQEYKEKLQKC CCHHHHHHHHHHHHH | 18.03 | 21214269 | |
| 156 | Ubiquitination | EYKEKLQKCLEPLEQ HHHHHHHHHHHHHHH | 51.75 | - | |
| 277 | Phosphorylation | IPRKFGGSLSTICPR CCHHHCCCHHHCCCC | 21.37 | - | |
| 279 | Phosphorylation | RKFGGSLSTICPRDH HHHCCCHHHCCCCCH | 19.88 | - | |
| 280 | Phosphorylation | KFGGSLSTICPRDHK HHCCCHHHCCCCCHH | 31.71 | - | |
| 304 | Phosphorylation | NRCEKVKTMEVTSVS HCCCCCEEEEEEEEE | 22.88 | 28060719 | |
| 308 | Phosphorylation | KVKTMEVTSVSIELE CCEEEEEEEEEEEEH | 15.31 | 28060719 | |
| 309 | Phosphorylation | VKTMEVTSVSIELEK CEEEEEEEEEEEEHH | 21.02 | 28060719 | |
| 311 | Phosphorylation | TMEVTSVSIELEKNF EEEEEEEEEEEHHHC | 15.31 | 21815630 | |
| 385 | Phosphorylation | FYPCVLATEGFTSGR CCEEEEECCCCCCCC | 32.26 | - | |
| 422 (in isoform 2) | Ubiquitination | - | 59.55 | 21890473 | |
| 422 | Ubiquitination | SRKGELTPLPETGYW CCCCCEECCCCCCEE | 59.55 | 21890473 | |
| 439 | Phosphorylation | RLWNGDKYAATTTPF EEECCCCCEEECCCC | 13.25 | 16094384 | |
| 452 (in isoform 1) | Ubiquitination | - | 33.20 | 21890473 | |
| 452 | Ubiquitination | PFTPLHIKVKPKRVG CCCCEEEEECCCEEE | 33.20 | 21890473 | |
| 452 | Ubiquitination | PFTPLHIKVKPKRVG CCCCEEEEECCCEEE | 33.20 | 21890473 | |
| 468 | Phosphorylation | FLDYEAGTLSFYNVT EEEEECCEEEEEECC | 26.69 | 22461510 | |
| 472 | Phosphorylation | EAGTLSFYNVTDRSH ECCEEEEEECCCCCC | 12.83 | 22461510 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TRI39_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TRI39_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TRI39_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteome analysis using a dendrimer conjugationchemistry and tandem mass spectrometry."; Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J.,Bodenmiller B., Watts J.D., Hood L., Aebersold R.; Nat. Methods 2:591-598(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-439, AND MASSSPECTROMETRY. | |